# Smith & Nephew Plc

Smith & Nephew Plc is an other based in London, United Kingdom.

## Overview

- **Organization type:** other
- **Headquarters:** London, United Kingdom
- **Region:** Europe
- **Address:** London, England, United Kingdom
- **Founded:** 1856
- **Assets under management:** Undisclosed
- **Website:** smith-nephew.com

## Regulatory record

- **Reports private funds:** No

## About

Smith & Nephew was founded in Hull, England in 1856 by Thomas Smith, a pharmacist who initially sold wound dressings. The company has evolved into a multinational medical technology business, listed on the London Stock Exchange and a constituent of the FTSE 100. Deepak Nath, a former Siemens Healthineers executive, became CEO in 2022. The firm's strategy focuses on three core segments: orthopedics (hip and knee replacements, robotic-assisted surgery via its NAVIO system), sports medicine and ENT (arthroscopy, joint repair, and sinus dilation), and advanced wound management (negative pressure therapy, antimicrobial dressings). Smith & Nephew generates roughly $5 billion in annual revenue. The company has a global manufacturing and R&D footprint spanning the US, UK, Ireland, Germany, and China. Known portfolio products include the CORI surgical robot and PICO single-use negative pressure wound therapy. Smith & Nephew employs approximately 18,000 people across more than 100 countries. The company maintains a dual-listed corporate structure but is headquartered in London with major operational hubs in Durham, North Carolina and Park City, Utah. The firm's philanthropic arm, the Smith & Nephew Foundation, supports healthcare education and research. 2024: Deepak Nath outlined a three-year strategic plan to improve margins and accelerate growth in robotics and emerging markets. The structural differentiator is Smith & Nephew's unique hybrid position as both a historic wound-care pioneer and a modern robotic-surgery contender, straddling legacy consumables and high-tech capital equipment. This dual mandate requires the company to manage contrasting R&D cycles and regulatory pathways, a balancing act few pure-play medtech firms face.

## Sectors

- MedTech
- Healthcare Services
- Surgical Robotics

## Offices

- Durham, North Carolina, United States
- Park City, Utah, United States

## People

- Deepak Nath — Chief Executive Officer
- John Rogers — Chairman

## Questions

### What are Smith & Nephew's main business segments?

The firm operates through three segments: Orthopaedics (hip/knee replacements and robotics), Sports Medicine & ENT (arthroscopy and sinus surgery), and Advanced Wound Management (dressings and negative pressure therapy). Together they generated approximately $5 billion in 2024 revenue (per the firm's annual report).

### Does Smith & Nephew have a focus on robotics?

Yes. The firm's NAVIO and CORI surgical robotics platforms compete in the robotic-assisted orthopedic surgery market, performing partial and total knee replacements. This is a key growth area alongside emerging market expansion (per the firm's 2024 strategic plan).

### How is Smith & Nephew's wealth origin connected to its founding?

The company was founded by Thomas Smith, a pharmacist who created the first sterile wound dressings. The original family wealth came from the success of that early medical-supply business. However, Smith & Nephew is now a widely held public company with no controlling family stake.

### Which markets does Smith & Nephew consider its strongest growth areas?

The firm targets growth in robotic-assisted surgery, emerging markets (especially China and India), and advanced wound bioactives. The 2024 strategic plan highlighted margin improvement and a portfolio shift toward higher-growth segments (per the firm's communications).

## Related profiles

- [Soleus Capital Management](https://altss.com/profile/soleus-capital-management)
- [Park Place Technologies LLC](https://altss.com/profile/park-place-technologies-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/smith-and-nephew-plc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology